WHO: Indian strain of COVID-19 resistant to antibodies
Mutations of the Indian strain of COVID-19 indicate its high infectivity and resistance to antibodies in both those who have been ill and vaccinated, the World Health Organization reported.
New varieties of the virus have been discovered in India, including B.1.617. It is a variant with mutations E484Q and L452R that was first identified in India from samples collected on December 1, 2020.
According to preliminary research results, the L452R mutation may interfere with the effectiveness of certain monoclonal antibody treatments. E484Q can neutralize antibodies. Thus, the antibodies that have appeared in a person who has recovered from COVID-19 will not help in the fight against Indian mutations.
Moreover, the new strain is also thought to be highly virulent, which means it is more likely to infect and cause disease.
WHO experts have not yet figured out what influenced the virus mutations in India. One of the factors could be the holding of mass events that increased its spread, as well as the mitigation of antiquated measures in the country.




















An unprecedented Evening for the Armenian Fashion and Hospitality Industry: World-Renowned Dress Des...
Team Holding Announces the Launch of Bond Placement. Underwriter - Freedom Broker Armenia
Acba bank and France’s Proparco to continue strengthening their long-term strategic partnership
Euromoney Names Ameriabank Armenia’s Best Bank for Real Estate for the Second Year in a Row
Apply for a Unibank salary card and get a chance to win 1 000 000 AMD
AraratBank Joins Armenia's New Greening Initiative: 100 Hectares of New Forest within Three Years
Unibank Issues the First in Armenia Perpetual Bonds
Unibank’s Perpetual Bonds Were Acquired in Nearly One Day
AraratBank Participates in “Women’s Empowerment Principles in Armenia” Conference
S&P Global Ratings has assigned IDBank CJSC a long-term rating of “BB-” and a short-term rating of “...